Literature DB >> 15761535

[Childhood adrenocortical tumors].

Rosana Marques Pereira1, Edson Michalkiewicz, Fabiano Sandrini, Bonald C Figueiredo, Mara Pianovski, Susana Nesi França, Margaret C S Boguszewski, Orival Costa, Izrail Cat, Luiz de Lacerda Filho, Romolo Sandrini.   

Abstract

Adrenocortical tumors (ACT) in children are uncommon. However, the incidence of these tumors in Paraná, Brazil, is 15 times higher than that worldwide. We describe the clinical, laboratory and treatment characteristics and outcome of 125 patients treated in a single institution in the State of Paraná. The median age at diagnosis was 4.3 years, with a female:male ratio of 2.6:1. The most common forms of presentation were isolated virilization (51.2%) and virilization and Cushing's syndrome (42%). Nonfunctioning tumors comprised 4.8% of the cases. Two patients (1.6%) had isolated Cushing's syndrome and 1 (0.8%) had Conn's syndrome. Fifty-six percent presented hypertension. Surgery is the only curative treatment. Our data show that disease stage 1, absence of spillage during surgery and absence of intravenous thrombus were associated with better survival rates.

Entities:  

Mesh:

Year:  2005        PMID: 15761535     DOI: 10.1590/s0004-27302004000500010

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  6 in total

1.  Childhood adrenocortical tumours: a review.

Authors:  Rosana Marques-Pereira; Luiz Delacerda; Hadriano M Lacerda; Edson Michalkiewicz; Fabiano Sandrini; Romolo Sandrini
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

2.  Psychological Impact of TP53-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort.

Authors:  Amanda Scartezini Gozdziejewski; Clarice Wichinescki Zotti; Isabela Aparecida Moreira de Carvalho; Thairine Camargo Dos Santos; Luana Rayana de Santi Walter; Karin Rosa Persegona Ogradowski; Karin Luiza Dammski; Heloisa Komechen; Monalisa Castilho Mendes; Emanuelle Nunes de Souza; Mariana Martins Paraizo; Ivy Zortea da Silva Parise; Guilherme Augusto Parise; André Luiz Grion; Gislaine Custódio; Rosiane Guetter Mello; Bonald C Figueiredo
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

3.  Adrenocortical carcinoma with extension to the inferior vena cava and right atrium: 20-month-old girl with TP53 mutation.

Authors:  Terry L Levin; Walter E Berdon; Daniel Weiser; Raul C Ribeiro
Journal:  Radiol Case Rep       Date:  2016-02-17

4.  ADRENAL CARCINOMA IN CHILDREN: LONGITUDINAL STUDY IN MINAS GERAIS, BRAZIL.

Authors:  Nonato Mendonça Lott Monteiro; Karla Emília de Sá Rodrigues; Paula Vieira Teixeira Vidigal; Benigna Maria de Oliveira
Journal:  Rev Paul Pediatr       Date:  2018-07-26

5.  Hypoxia-induced endothelial progenitor cell function is blunted in angiotensinogen knockout mice.

Authors:  Jin-Hwa Choi; Minh-Phuong Nguyen; Dongjin Lee; Goo-Taeg Oh; You-Mie Lee
Journal:  Mol Cells       Date:  2014-06-18       Impact factor: 5.034

6.  Penetrance of the TP53 R337H Mutation and Pediatric Adrenocortical Carcinoma Incidence Associated with Environmental Influences in a 12-Year Observational Cohort in Southern Brazil.

Authors:  Tatiana E J Costa; Viviane K Q Gerber; Humberto C Ibañez; Viviane S Melanda; Ivy Z S Parise; Flora M Watanabe; Mara A D Pianovski; Carmem M C M Fiori; Ana L M R Fabro; Denise B da Silva; Diancarlos P Andrade; Heloisa Komechen; Monalisa C Mendes; Edna Carboni; Ana Paula Kuczynski; Emanuelle N Souza; Mariana M Paraizo; Marilea V C Ibañez; Laura M Castilho; Amanda F Cruz; Thuila F da Maia; Cleber Machado-Souza; Roberto Rosati; Claudia S Oliveira; Guilherme A Parise; Jaqueline D C Passos; José R S Barbosa; Mirna M O Figueiredo; Leniza Lima; Tiago Tormen; Cesar C Sabbaga; Sylvio G A Ávilla; Leila Grisa; Airton Aranha; Karina C F Tosin; Karin R P Ogradowski; Geneci Lima; Edith F Legal; Tania H Anegawa; Tânia L Mazzuco; André L Grion; José H G Balbinotti; Karin L Dammski; Rosiane G Melo; Nilton Kiesel Filho; Gislaine Custódio; Bonald C Figueiredo
Journal:  Cancers (Basel)       Date:  2019-11-16       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.